Wilmot Cancer Institute lead site connecting patients to national cancer treatment opportunities
Rochester Network Lead Academic Participating Site
This program runs national cancer clinical trials to give adult cancer patients at the University of Rochester access to new treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11291084 on NIH RePORTER |
What this research studies
If you come to the Wilmot Cancer Institute, this program helps open and run national cancer clinical trials at Rochester so patients can join treatment trials close to home. A team of doctors across medical oncology, radiation oncology, surgery, and hematology leads these efforts, enrolls eligible patients, and collects clinical data and biological samples for the national network. The focus is on late-phase trials that test promising therapies in larger groups of patients. The program also supports leadership, mentorship, and timely data and specimen submission to keep trials moving efficiently.
Who could benefit from this research
Good fit: Adults with cancer who meet eligibility for NCI National Clinical Trials Network late-phase trials at the University of Rochester/Wilmot Cancer Institute are ideal candidates.
Not a fit: Patients who do not meet trial eligibility, have cancers not included in open trials, or cannot travel to Rochester are unlikely to benefit directly from this site program.
Why it matters
Potential benefit: If successful, patients could have expanded local access to newer treatments and faster entry into national cancer trials.
How similar studies have performed: This follows a proven NCTN model—Wilmot and other NCTN lead sites have previously opened trials and enrolled patients, with Wilmot averaging about 157 patient enrollments per year between 2019 and 2024.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Barr, Paul M — University of Rochester
- Study coordinator: Barr, Paul M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.